Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

Diabetes Care. 2000 Apr;23(4):490-4. doi: 10.2337/diacare.23.4.490.

Abstract

Objective: The objective was to examine prospectively the association between low testosterone and sex hormone-binding globulin (SHBG) levels and the subsequent development of type 2 diabetes in men.

Research design and methods: Analyses were conducted on the cohort of the Massachusetts Male Aging Study, a population-based random sample of men aged 40-70. Of the 1,709 men enrolled in 1987-1989 (T1), 1,156 were followed up 7-10 years later (T2). Testosterone and SHBG levels at T1 were used to predict new cases of diabetes between T1 and T2.

Results: After controlling for potential confounders, diabetes at follow-up was predicted jointly and independently by lower baseline levels of free testosterone and SHBG. The odds ratio for future diabetes was 1.58 for a decrease of 1SD in free testosterone (4 ng/dl) and 1.89 for a 1SD decrease in SHBG (16 nmol/l), both significant at P < 0.02.

Conclusions: Our prospective findings are consistent with previous, mainly cross-sectional reports, suggesting that low levels of testosterone and SHBG play some role in the development of insulin resistance and subsequent type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aging
  • Cohort Studies
  • Continental Population Groups
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Health Behavior
  • Heart Diseases / epidemiology
  • Humans
  • Hypertension / epidemiology
  • Longitudinal Studies
  • Male
  • Massachusetts / epidemiology
  • Middle Aged
  • Predictive Value of Tests
  • Sex Hormone-Binding Globulin / analysis*
  • Testosterone / blood*
  • Time Factors

Substances

  • Sex Hormone-Binding Globulin
  • Testosterone